Associations of Novel Visceral Obesity Indices (METS-VF and BRI) with Dementia: The Role of Metabolic Mediators and Genetic Susceptibility

Why It Matters

Visceral obesity, as measured by METS‑VF and BRI, emerges as a modifiable risk factor for dementia, offering new targets for prevention and more precise risk stratification than traditional BMI metrics.

Key Takeaways

• METS‑VF and BRI best correlate with MRI/DXA visceral fat.
• Higher METS‑VF raises all‑cause dementia risk by 25% per SD.
• Vascular dementia risk climbs 49% with each SD increase in METS‑VF.
• BRI predicts dementia; AD link weakens after full adjustment.
• Metabolic dysfunction partially mediates visceral obesity‑dementia association.

Pulse Analysis

The global dementia burden is projected to more than double by 2050, prompting researchers to hunt for modifiable contributors. While obesity has long been implicated, most epidemiologic work relied on body mass index, which cannot distinguish harmful visceral fat from subcutaneous tissue. Recent advances in anthropometric modeling—namely the metabolic score for visceral fat (METS‑VF) and the body roundness index (BRI)—offer inexpensive proxies for visceral adiposity that align closely with imaging‑derived measurements. By validating these indices against MRI and DXA scans in a large UK cohort, the study confirms they capture the metabolically active fat depot most linked to cardiometabolic disease.

Beyond validation, the analysis reveals a robust, dose‑responsive relationship between visceral obesity and incident dementia. Each standard‑deviation rise in METS‑VF translates to a 25% higher risk of all‑cause dementia and nearly a 50% jump in vascular dementia, while BRI also predicts elevated risk across dementia subtypes. Notably, METS‑VF exhibits a nonlinear threshold, suggesting that risk accelerates once visceral fat surpasses a critical level. These patterns persist after adjusting for traditional risk factors, underscoring visceral fat’s independent contribution. Mediation modeling further indicates that metabolic disturbances—elevated glucose, triglycerides, and altered lipids—partially drive the observed associations, linking the obesity‑dementia axis to systemic metabolic health.

For clinicians and policymakers, the findings advocate integrating visceral obesity indices into routine risk assessments, especially for middle‑aged adults. Unlike BMI, METS‑VF and BRI can flag high‑risk individuals before overt weight changes appear, enabling early lifestyle or pharmacologic interventions aimed at reducing visceral fat and its metabolic sequelae. Future research should explore whether targeted reductions in METS‑VF, through diet, exercise, or emerging anti‑obesity therapies, can attenuate dementia incidence, and how these measures perform across diverse ethnic groups. As the field moves toward precision prevention, visceral obesity metrics may become pivotal tools in curbing the looming dementia epidemic.